Our offering is aimed at any company innovating in skin health, whether it involves a digital medical device, an AI solution in clinical dermatology, or a cosmetic innovation requiring rigorous scientific validation. The Tiers-Lieu d’Expérimentation SKIN supports every project for which clinical and digital expertise creates real added value.
Our offering can be used as a complete pathway, for projects starting from scratch that want to secure each step, or in modular mode, for companies that have already progressed and are looking for targeted support on a specific challenge.
Partnership project with public funding
You want to develop an ambitious innovation and are looking to fund it through public project calls specific to Tiers Lieux d’Expérimentation or others (ANR, BPI France, European Horizon Europe programs, PSPC, or regional calls). TLE SKIN can act as a consortium partner: we co-build the application with you and contribute our clinical expertise (CHU de Nice, Prof. Passeron), numerical expertise (INRIA), and testing grounds (patients, general practitioners, and independent dermatologists).
Partnership project with private funding
You have a specific need: a clinical study to conduct, an algorithm to develop or validate, a protocol to draft, a regulatory strategy to build, or a funding application to prepare. TLE SKIN intervenes as a service provider: we provide you with the right expertise at the right time, with no obligation of co-publication or IP sharing.
This mode is particularly suited for companies that have already advanced in their project and are looking for targeted expert support, without necessarily committing to a full pathway.
These two approaches are not mutually exclusive: a project can start as a service contract and evolve into a partnership on a project call, or vice versa.
Start with Phase 1 (De-risking) to quickly define the scope of your medical or cosmetic project. Based on the results, we will guide you toward a targeted service or toward building a partnership application.
Go directly to Phase 2 or 3 depending on your needs: clinical co-design with our dermatologists, or studies led by CHU de Nice, algorithm and AI tool development, clinical regulatory evaluation, CE marking preparation, health economics study.
Focus on Phase 4: market authorisation, reimbursement strategy, intellectual property protection, RESAH catalogue access, and first hospital contracts.
Strengthen your solution toward a new claim, prepare a certification with additional clinical results
Frame your project to move forward fast
Ideal for: proof-of-concept (PoC), early-stage ideas — medical or cosmetic projects
At this stage, healthcare professionals from the consortium intervene to qualify the actual clinical need and assess the relevance of your solution, whether it targets medical care or cosmetic efficacy. Avoiding investment in a direction the field will not adopt is often the first and most tangible value TLE SKIN provides.
Deliverables:
Co-build with experts
Ideal for: an MVP to refine, or a solution to validate in real-world clinical conditions
Dermatologists, clinicians, and patients actively participate in co-design workshops ensuring the solution is not only technically sound, but clinically relevant and adoptable in real-world practice. For cosmetic projects, this phase builds the clinical evidence base that strongly validates a claim.
INRIA intervenes at this phase to structure the databases, validate algorithmic approaches, and ensure the scientific robustness of AI developments.
Deliverables:
The scientific proof that opens doors
Ideal for solutions requiring clinical validation, typically in a partnership project with CHU as sponsor
The CHU de Nice can directly sponsor clinical studies within the consortium. For cosmetic industry players, having a clinical study conducted by a leading university dermatology department and published in an international peer-reviewed journal is a top-tier commercial and regulatory asset.
Deliverables:
From Validation to Market
Ideal for: validated solution ready to be commercialized
Market access channels vary depending on your sector. For medical solutions, the RESAH catalog provides direct access to 3,000 healthcare facilities. For cosmetic and dermopharmaceutical companies, TLE SKIN mobilizes its network of independent dermatologists and commercial partners to facilitate product listing and first contracts.
In all cases, Eurobiomed supports projects in their search for additional funding and their path to final regulatory compliance.
Deliverables:
Measurable impacts:
